Investing.com - TD Cowen reiterated its Buy rating and $100.00 price target on DexCom (NASDAQ:DXCM) on Thursday, citing resolution of earlier issues with the company’s G7 continuous glucose monitoring ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them. DexCom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) ...
10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ...
With significant upside potential, DexCom, Inc. (NASDAQ:DXCM) secures a spot on our list of the 13 Best Quality Stocks to Buy According to Hedge Funds. On September 25, 2025, given that previous ...
Shares of DexCom Inc. DXCM slid 1.80% to $66.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.34% to 6,711.20 and ...
Fintel reports that on September 29, 2025, Canaccord Genuity maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation. Analyst Price Forecast Suggests 57.07% Upside As of September 13, ...
Kingston’s new Renegade G5 aced our performance testing, falling a hair shy of the overall top spot. But it took the top spot in Consumer grade SSD warranties with a 1PB per terabyte TBW rating. I ...
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback